Ivermectin & Generics: Will Patent Cliff Fuel Off-Label Use?

ein Foto hinzugefügt Health

2025-07-10 09:46:28 -

The U.S. pharmaceutical industry is bracing for one of the most influential shifts of 2025: ivermectin’s patent cliff. As this long-debated antiparasitic drug enters the generic realm, a whirlwind of regulatory, economic, and public health changes is expected. But among these changes, one question stands out: Will generic ivermectin’s wider availability lead to an increase...

0 Kommentare 0 Anteile 36 Ansichten 0 Vorschau